RAPTOR

BRVO // Clinical Trials // Macular Edema // Michael Altaweel // Past // Retinal Vein Occlusion // Jun 12 2019

An Eighteen-Month, Two-Arm, Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients with Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (RAPTOR)

Sponsor: Novartis Pharmaceuticals

CLINICALTRIALS.GOVĀ